{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["35"],"submitter":["Nuamek T"],"pubmed_abstract":["There is an unmet need in patient monitoring between the end of radiotherapy and the first follow-up appointment during which patients may experience severe side effects. Personalised follow-up has the potential to tailor healthcare to individual needs. ePROMs enable remote monitoring and identification of those needing earlier intervention. To assess the feasibility of integrating ePROMs into personalised follow-up of patients after radiotherapy. Patients with lung or head and neck (HN) cancer were enrolled. ePROMs questionnaires, comprising EQ-5D-5L and 14 lung or 19 HN cancer-specific questions adapted from CTCAE v5.0, were sent to patients at eight timepoints: pre-radiotherapy, mid-radiotherapy, end of radiotherapy, weekly for four weeks post-treatment, and first face-to-face follow-up appointment. Upon completion, automated advice was provided based on responses. Grade 2 or above symptoms were escalated to clinicians. Patient feedback was obtained through structured interviews. Over two months, 19 eligible patients (10 lung, 9 HN) were recruited: 13 received concurrent chemoradiotherapy, and six received radiotherapy alone. ePROMs completion rate was 69.1%, ranging from 47.4% to 89.5% at each timepoint. Three patients reported grade 3 or above symptoms on 5 instances during and after radiotherapy. Fourteen patients participated in the interviews: all 14 reported ePROMs were easy to complete, took an acceptable amount of time, and made them feel better supported. Integrating ePROMs into personalised follow-up is feasible and acceptable to patients. ePROMs provide insights into patients' symptoms during and after radiotherapy, highlighting the need for a tailored approach."],"journal":["Technical innovations & patient support in radiation oncology"],"pagination":["100333"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12365331"],"repository":["biostudies-literature"],"pubmed_title":["Integrating Electronic Patient-Reported Outcome Measures (ePROMs) into Personalised Follow-up for Patients after Radiotherapy. A Feasibility Study."],"pmcid":["PMC12365331"],"pubmed_authors":["Harris M","Price J","Woolf D","Bowen Jones S","Nuamek T","Horne A","Gurumurthy G","Barker C","Yorke J","Chan C","Thomson D","Abdulwahid D","Banfill K","Pemberton L","Payne A","King J","Faivre-Finn C","Sheikh HY","Kwateng PAN","Bayman N"],"additional_accession":[]},"is_claimable":false,"name":"Integrating Electronic Patient-Reported Outcome Measures (ePROMs) into Personalised Follow-up for Patients after Radiotherapy. A Feasibility Study.","description":"There is an unmet need in patient monitoring between the end of radiotherapy and the first follow-up appointment during which patients may experience severe side effects. Personalised follow-up has the potential to tailor healthcare to individual needs. ePROMs enable remote monitoring and identification of those needing earlier intervention. To assess the feasibility of integrating ePROMs into personalised follow-up of patients after radiotherapy. Patients with lung or head and neck (HN) cancer were enrolled. ePROMs questionnaires, comprising EQ-5D-5L and 14 lung or 19 HN cancer-specific questions adapted from CTCAE v5.0, were sent to patients at eight timepoints: pre-radiotherapy, mid-radiotherapy, end of radiotherapy, weekly for four weeks post-treatment, and first face-to-face follow-up appointment. Upon completion, automated advice was provided based on responses. Grade 2 or above symptoms were escalated to clinicians. Patient feedback was obtained through structured interviews. Over two months, 19 eligible patients (10 lung, 9 HN) were recruited: 13 received concurrent chemoradiotherapy, and six received radiotherapy alone. ePROMs completion rate was 69.1%, ranging from 47.4% to 89.5% at each timepoint. Three patients reported grade 3 or above symptoms on 5 instances during and after radiotherapy. Fourteen patients participated in the interviews: all 14 reported ePROMs were easy to complete, took an acceptable amount of time, and made them feel better supported. Integrating ePROMs into personalised follow-up is feasible and acceptable to patients. ePROMs provide insights into patients' symptoms during and after radiotherapy, highlighting the need for a tailored approach.","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Sep","modification":"2026-05-07T00:14:36.261Z","creation":"2026-04-07T22:21:17.835Z"},"accession":"S-EPMC12365331","cross_references":{"pubmed":["40842525"],"doi":["10.1016/j.tipsro.2025.100333"]}}